82 related articles for article (PubMed ID: 34840594)
1. A nomogram based on 4-lncRNAs signature for improving prognostic prediction of hepatocellular carcinoma.
Mo Q; Li W; Liu L; Hao Z; Jia S; Duo Y
Clin Transl Oncol; 2024 Feb; 26(2):375-388. PubMed ID: 37368201
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma.
Duan BT; Zhao XK; Cui YY; Liu DZ; Wang L; Zhou L; Zhang XY
World J Gastrointest Surg; 2024 Mar; 16(3):842-859. PubMed ID: 38577085
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA signature for predicting gastric cancer survival based on genomic instability.
Zhang J; Chen L; Wei W; Mao F
Aging (Albany NY); 2023 Dec; 15(24):15114-15133. PubMed ID: 38127056
[TBL] [Abstract][Full Text] [Related]
4. Identification of a vascular invasion-related signature based on lncRNA pairs for predicting prognosis in hepatocellular carcinoma.
Zhao N; Ni C; Zhang D; Che N; Li Y; Wang X
BMC Gastroenterol; 2024 Jan; 24(1):33. PubMed ID: 38221614
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel ferroptosis-correlative lncRNA signature and validation of ST3GAL4-AS1 for predicting overall survival of hepatocellular carcinoma.
Xuan Z; Liu L; Huang P; Ye Q
Asian J Surg; 2024 May; 47(5):2524-2526. PubMed ID: 38378408
[No Abstract] [Full Text] [Related]
6. Development of an RNA modification writer-related lncRNA signature to predict prognosis, tumor microenvironment, and treatment outcome for hepatocellular carcinoma.
Zhong L; Zhang Y; Jifeng L; Guang T
Asian J Surg; 2024 Jan; 47(1):723-725. PubMed ID: 37891117
[No Abstract] [Full Text] [Related]
7. A robust genomic-based prognostic model for the assessment of cancer stemness and survival for patients with hepatocellular carcinoma.
Du CL; Wei SY; Chen YH; Chen KJ
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):97-102. PubMed ID: 37709605
[No Abstract] [Full Text] [Related]
8. Reply to: "developing real‑world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond".
Hatanaka T; Kakizaki S; Hiraoka A; Toyoda H; Kumada T
Hepatol Int; 2023 Oct; 17(5):1320-1321. PubMed ID: 37269477
[No Abstract] [Full Text] [Related]
9. Retraction Note: Identification of biomarkers of hepatocellular carcinoma gene prognosis based on the immune-related lncRNA signature of transcriptome data.
Ma A; Sun Y; Ogbodu RO; Xiao L; Deng H; Zhou H
Funct Integr Genomics; 2024 May; 24(3):87. PubMed ID: 38730114
[No Abstract] [Full Text] [Related]
10. Comprehensive genomic analysis of early and late-onset hepatocellular carcinoma.
Yang J; Chen C; Wang S; Zhang Y; Pang J; Wang Y; Ou Q; Jiang H; Liu J
Genes Dis; 2024 Jul; 11(4):101031. PubMed ID: 38510473
[No Abstract] [Full Text] [Related]
11. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
Front Immunol; 2022; 13():929846. PubMed ID: 35990656
[TBL] [Abstract][Full Text] [Related]
12. Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer.
Tang D; Li GS; Xu RX; Zhu SY; Luo J; Zheng JH; Liu J; Lu HS; Jin MH; Bao CX; Tian J; Deng WS; Zeng NY; Zhou HF; Kong JL; Chen G
J Oncol; 2022; 2022():2010341. PubMed ID: 35356257
[TBL] [Abstract][Full Text] [Related]
13. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.
Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD
Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469
[TBL] [Abstract][Full Text] [Related]
14. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
[TBL] [Abstract][Full Text] [Related]
15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
16. The Expressions and Functions of lncRNA Related to m6A in Hepatocellular Carcinoma from a Bioinformatics Analysis.
Du S; Guo Y; Huang J; Xu J; Chen G
Comput Math Methods Med; 2022; 2022():1395557. PubMed ID: 36276996
[TBL] [Abstract][Full Text] [Related]
17. Emerging role for R-loop formation in hepatocellular carcinoma.
Baek H; Park SU; Kim J
Genes Genomics; 2023 May; 45(5):543-551. PubMed ID: 36635460
[TBL] [Abstract][Full Text] [Related]
18. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.
Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D
Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
